SCHEDULE: Artisan Partners Discloses 5.2% Passive Stake in RxSIGHT

Artisan Partners Asset Management Inc. and its affiliates have reported a 5.2% passive beneficial ownership stake in RxSIGHT, Inc. common stock.

Summary

• Artisan Partners Asset Management Inc., along with its affiliates Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership, has disclosed a beneficial ownership of 2,157,264 shares of RxSIGHT, Inc. common stock.
• This ownership represents 5.2% of RxSIGHT, Inc.'s outstanding common stock, based on 41,116,640 shares outstanding as of October 30, 2025.
• The reporting persons hold shared voting power over 1,955,441 shares and shared dispositive power over all 2,157,264 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of RxSIGHT, Inc.
• The investment is made on behalf of discretionary clients of Artisan Partners Limited Partnership, with no single client holding an economic interest exceeding 5% of the class.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development. The disclosure of a significant passive stake by a major asset manager like Artisan Partners can instill investor confidence, suggesting a belief in the company's value proposition without immediate activist intentions.

Positives

• A significant institutional investor, Artisan Partners, has taken a 5.2% stake in RxSIGHT, Inc., which can be interpreted as a signal of confidence in the company's long-term prospects.
• The investment is stated to be for passive purposes, indicating no immediate intent to influence control or management, which can provide stability to the company's current strategic direction.

Risks

• The filing does not detail specific risks related to RxSIGHT, Inc.'s operations or financial health.
• As a passive investment, Artisan Partners does not intend to influence control, meaning their stake may not actively drive strategic changes or improvements within RxSIGHT, Inc.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

StockSavvy.ai notes that a significant passive stake by a reputable asset manager like Artisan Partners can often be viewed positively by the market, suggesting that the company has passed a certain level of institutional due diligence. This type of investment typically reflects a long-term view on the company's sector, which for RxSIGHT, Inc. (likely in ophthalmology or vision technology given its name), could indicate confidence in the growth trajectory of specialized medical devices or healthcare technology.

Comparison to Industry Standards

• The filing does not provide performance data for RxSIGHT, Inc. to compare against industry standards or competitors.
• A 5.2% stake by an institutional investor is a common occurrence in publicly traded companies, indicating a standard level of institutional interest and a vote of confidence in the company's market position.

Stakeholder Impact

• Shareholders: May view the entry of a significant institutional investor as a positive signal, potentially leading to increased share price stability or upward movement.
• Management: The passive nature of the investment suggests no immediate pressure for strategic changes, allowing management to continue executing its current plans.

Key Dates

Recommendation

The disclosure of a 5.2% passive stake by Artisan Partners is generally a positive signal, indicating institutional confidence. However, as a Schedule 13G, it does not provide new operational or financial data about RxSIGHT, Inc. to warrant a 'buy' recommendation. It confirms a significant investor sees value, but without further fundamental analysis of the company's performance, a 'hold' is appropriate for existing investors, while potential investors should conduct further due diligence.

Keywords

RxSIGHT, Artisan Partners, Asset Management, Institutional Ownership, Common Stock, SEC Filing, Schedule 13G, Beneficial Ownership, Investment Adviser, Healthcare Technology